Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
NK cell defects in X-linked pigmentary reticulate disorder
Petro Starokadomskyy, Katelynn M. Wilton, Konrad Krzewski, Adam Lopez, Luis Sifuentes-Dominguez, Brittany Overlee, Qing Chen, Ann Ray, Aleksandra Gil-Krzewska, Mary Peterson, Lisa N. Kinch, Luis Rohena, Eyal Grunebaum, Andrew R. Zinn, Nick V. Grishin, Daniel D. Billadeau, Ezra Burstein
Petro Starokadomskyy, Katelynn M. Wilton, Konrad Krzewski, Adam Lopez, Luis Sifuentes-Dominguez, Brittany Overlee, Qing Chen, Ann Ray, Aleksandra Gil-Krzewska, Mary Peterson, Lisa N. Kinch, Luis Rohena, Eyal Grunebaum, Andrew R. Zinn, Nick V. Grishin, Daniel D. Billadeau, Ezra Burstein
View: Text | PDF
Research Article Infectious disease Inflammation

NK cell defects in X-linked pigmentary reticulate disorder

  • Text
  • PDF
Abstract

X-linked reticulate pigmentary disorder (XLPDR, Mendelian Inheritance in Man #301220) is a rare syndrome characterized by recurrent infections and sterile multiorgan inflammation. The syndrome is caused by an intronic mutation in POLA1, the gene encoding the catalytic subunit of DNA polymerase-α (Pol-α), which is responsible for Okazaki fragment synthesis during DNA replication. Reduced POLA1 expression in this condition triggers spontaneous type I interferon expression, which can be linked to the autoinflammatory manifestations of the disease. However, the history of recurrent infections in this syndrome is as yet unexplained. Here we report that patients with XLPDR have reduced NK cell cytotoxic activity and decreased numbers of NK cells, particularly differentiated, stage V, cells (CD3–CD56dim). This phenotype is reminiscent of hypomorphic mutations in MCM4, which encodes a component of the minichromosome maintenance (MCM) helicase complex that is functionally linked to Pol-α during the DNA replication process. We find that POLA1 deficiency leads to MCM4 depletion and that both can impair NK cell natural cytotoxicity and show that this is due to a defect in lytic granule polarization. Altogether, our study provides mechanistic connections between Pol-α and the MCM complex and demonstrates their relevance in NK cell function.

Authors

Petro Starokadomskyy, Katelynn M. Wilton, Konrad Krzewski, Adam Lopez, Luis Sifuentes-Dominguez, Brittany Overlee, Qing Chen, Ann Ray, Aleksandra Gil-Krzewska, Mary Peterson, Lisa N. Kinch, Luis Rohena, Eyal Grunebaum, Andrew R. Zinn, Nick V. Grishin, Daniel D. Billadeau, Ezra Burstein

×

Figure 4

POLA1 does not affect cell cycle progression and DNA integrity.

Options: View larger image (or click on image) Download as PowerPoint
POLA1 does not affect cell cycle progression and DNA integrity.
(A) Flow...
(A) Flow cytometry analysis of NK cell proliferation (based on CFSE dilution) was performed on days 3 and 7 in NK cells isolated from unaffected individuals (UA4, UA5, UA8) and from XLPDR probands (P1, P2, P3). Error bars represent the SEM. XLPDR and UA groups are not different at every division number (P > 0.05 by 2-way ANOVA). Data are representative of 2 independent experiments. (B) Flow cytometry analysis of apoptosis and necrosis (based on annexin V staining) was performed on day 14 in proliferating NK cells as above. Data are the result of 1 experiment. Black bars indicate the mean and error bars represent the SD. (P > 0.05 by 2-way ANOVA.) (C) Quantification of the number of DNA-damaging events per nucleus (colocalized H2AγX and 53BP1 foci) is presented. Each dot represents a cell in each group. Bars correspond to the group average, and error bars correspond to the SD. NS, nonsignificant when compared to its corresponding control (P > 0.05 by 2-way ANOVA). (D) Representative images of DNA damage foci assessed by immunofluorescence staining and confocal microscopy imaging for nuclear H2AγX and 53BP1. Dermal fibroblasts from an XLPDR patient that were rescued for POLA1 expression (P3 + POLA1) were compared to an isogenic control line (P3 + EV) and to fibroblasts from P6. Staining at baseline and after etoposide treatment (1 μM, 5 hours) is shown. Scale bar: 2 μm. Representative images were derived from 2 independent experiments.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts